Reuters logo
BRIEF-Sonoma Pharmaceuticals says receives two new UAE regulatory approvals, Pediacyn® for atopic dermatitis and Epicyn® for scar management
2017年4月12日 / 早上8点30分 / 5 个月前

BRIEF-Sonoma Pharmaceuticals says receives two new UAE regulatory approvals, Pediacyn® for atopic dermatitis and Epicyn® for scar management

April 12 (Reuters) - Sonoma Pharmaceuticals Inc

* Sonoma Pharmaceuticals - receives two new united arab emirates regulatory approvals: Pediacyn® for atopic dermatitis and Epicyn® for scar management

* Sonoma Pharmaceuticals - both offerings, based upon Sonoma’s patented Microcyn® Technology hypochlorous acid, will be supplied by MicroSafe Group to UAE beginning in may 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below